Kun Liu

State Key Laboratory Of Discovery And Utilization Of Functional Components In Traditional Chinese Medicine
Guiyang, 550014, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Structure-optimized 4-trifluoromethylquinoline derivatives: Dual enhancement of SGK1 inhibition and anti-prostate cancer efficacy.

Structure-optimized 4-trifluoromethylquinoline derivatives: Dual enhancement of SGK1 inhibition and anti-prostate cancer efficacy.

Journal: Bioorganic chemistry

Published: February 26, 2026

Design, synthesis, and anti-prostate cancer activity evaluation of novel thieno[2,3-b]pyridine derivatives as potential BLM helicase inhibitors.

Design, synthesis, and anti-prostate cancer activity evaluation of novel thieno[2,3-b]pyridine derivatives as potential BLM helicase inhibitors.

Journal: Molecular diversity

Published: February 14, 2026

The regulation and mechanism of Rhodotorula mucilaginosa for the growth and antimony accumulation of rice under antimony stress.

The regulation and mechanism of Rhodotorula mucilaginosa for the growth and antimony accumulation of rice under antimony stress.

Journal: Ecotoxicology and environmental safety

Published: November 19, 2025

Novel trifluoromethylquinoline derivatives as potent tubulin polymerization inhibitors with antitumor activity.

Novel trifluoromethylquinoline derivatives as potent tubulin polymerization inhibitors with antitumor activity.

Journal: Bioorganic & medicinal chemistry

Published: August 07, 2025

Integrative bioinformatics reveals complement dysregulation: critical insights into C1q, C1r, and C1s in aortic dissection pathogenesis.

Integrative bioinformatics reveals complement dysregulation: critical insights into C1q, C1r, and C1s in aortic dissection pathogenesis.

Journal: Molecular genetics and genomics : MGG

Published: August 03, 2025

Activation of GPR81 protects against myocardial ischemia-reperfusion injury under aberrant glucose metabolism condition by modulating VILIP-1/GRK2/GLUT4 pathway.

Activation of GPR81 protects against myocardial ischemia-reperfusion injury under aberrant glucose metabolism condition by modulating VILIP-1/GRK2/GLUT4 pathway.

Journal: International journal of biological macromolecules

Published: August 01, 2025

Analysis of hub genes temporal dynamics in cardiac ischemia/reperfusion injury: a bioinformatics and experimental study.

Analysis of hub genes temporal dynamics in cardiac ischemia/reperfusion injury: a bioinformatics and experimental study.

Journal: Frontiers in physiology

Published: July 18, 2025

Correction: Discovery of novel 4-trifluoromethyl-2-anilinoquinoline derivatives as potential anti-cancer agents targeting SGK1.

Correction: Discovery of novel 4-trifluoromethyl-2-anilinoquinoline derivatives as potential anti-cancer agents targeting SGK1.

Journal: Molecular diversity

Published: April 29, 2025

Discovery of novel quinazoline derivatives containing trifluoromethyl against cell proliferation by targeting werner helicase.

Discovery of novel quinazoline derivatives containing trifluoromethyl against cell proliferation by targeting werner helicase.

Journal: Molecular diversity

Published: January 22, 2025

Correction: Exploring the therapeutic potential of Sirt6-enriched adipose stem cell-derived exosomes in myocardial ischemia-reperfusion injury: unfolding new epigenetic frontiers.

Correction: Exploring the therapeutic potential of Sirt6-enriched adipose stem cell-derived exosomes in myocardial ischemia-reperfusion injury: unfolding new epigenetic frontiers.

Journal: Clinical epigenetics

Published: December 20, 2024

Hit to lead optimization of the 4-trifluoromethylquinoline derivatives as novel SGK1 inhibitors with potent anti-prostate cancer activity.

Hit to lead optimization of the 4-trifluoromethylquinoline derivatives as novel SGK1 inhibitors with potent anti-prostate cancer activity.

Journal: European journal of medicinal chemistry

Published: October 22, 2024

Discovery of novel 4-trifluoromethyl-2-anilinoquinoline derivatives as potential anti-cancer agents targeting SGK1.

Discovery of novel 4-trifluoromethyl-2-anilinoquinoline derivatives as potential anti-cancer agents targeting SGK1.

Journal: Molecular diversity

Published: June 12, 2024

Showing 1-12 of 22

Last Updated: 09/26/2026